Cargando…
Detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear
INTRODUCTION: Endometrial lesions are morphologically diverse and uncommon on cervical smears, with its detection rate and associated diagnostic categories uncharacterized. In this study, cervical smears matched to histologically proven endometrial hyperplasias and carcinomas were reviewed and compa...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523982/ https://www.ncbi.nlm.nih.gov/pubmed/37501510 http://dx.doi.org/10.1002/cam4.6376 |
_version_ | 1785110656640352256 |
---|---|
author | Ng, Joanna K. M. Cheung, Bryan H. C. Lee, Dennis H. Y. Li, Joshua J. X. Ip, Philip P. C. Lee, Jacqueline H. S. Yeung, Carol S. Y. Yu, Mei‐Yung |
author_facet | Ng, Joanna K. M. Cheung, Bryan H. C. Lee, Dennis H. Y. Li, Joshua J. X. Ip, Philip P. C. Lee, Jacqueline H. S. Yeung, Carol S. Y. Yu, Mei‐Yung |
author_sort | Ng, Joanna K. M. |
collection | PubMed |
description | INTRODUCTION: Endometrial lesions are morphologically diverse and uncommon on cervical smears, with its detection rate and associated diagnostic categories uncharacterized. In this study, cervical smears matched to histologically proven endometrial hyperplasias and carcinomas were reviewed and compared with cervical in‐situ‐carcinomas/carcinomas, aiming to detail the diagnostic performance of cervical smears for upper tract and glandular lesions. METHODS: Pathology reports of cervical smears, hysterectomies, endometrial and cervical biopsies from 1995 to 2021 were retrieved. Diagnoses of cervical smears were matched to endometrial hyperplasias and carcinomas, or cervical carcinomas and reviewed. RESULTS: Totally 832 cervical smears (272 cervical carcinomas, 312 endometrial carcinomas, and 248 hyperplasias) were included. Considering all cytologic glandular diagnosis as positive, the detection rate of cervical adenocarcinoma‐in‐situ was the highest (64.3%), followed by cervical adenocarcinoma (63.8%), endometrial carcinoma (31.7%), and hyperplasia (with atypia–8.5%; without atypia–2.3%) (p < 0.001). Endometrial hyperplasia was most often diagnosed as atypical squamous cells of undetermined significance (ASCUS) (5.0%) or atypical glandular cells, not otherwise specified (3.6%) without indication of endometrial origin. For endometrial carcinomas, higher FIGO grading and endocervical involvement were associated with higher detection rates across all diagnostic categories (p = 0.002–0.028). High FIGO grade was associated with suspicious/favor neoplastic (C4) (31.1%vs10.3%, p < 0.001) and carcinoma (C5) (17.8% vs. 5.6%, p = 0.005) categories, but not for all glandular diagnoses combined (33.3% vs. 31.0%, p = 0.761). CONCLUSION: Detection rates for endometrial lesions are lower than cervical lesions but not insignificant. Endometrial hyperplasia should be recognized as a differential of human papilloma virus‐negative ASCUS and prompt consideration of investigation of the upper genital tract. |
format | Online Article Text |
id | pubmed-10523982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105239822023-09-28 Detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear Ng, Joanna K. M. Cheung, Bryan H. C. Lee, Dennis H. Y. Li, Joshua J. X. Ip, Philip P. C. Lee, Jacqueline H. S. Yeung, Carol S. Y. Yu, Mei‐Yung Cancer Med RESEARCH ARTICLES INTRODUCTION: Endometrial lesions are morphologically diverse and uncommon on cervical smears, with its detection rate and associated diagnostic categories uncharacterized. In this study, cervical smears matched to histologically proven endometrial hyperplasias and carcinomas were reviewed and compared with cervical in‐situ‐carcinomas/carcinomas, aiming to detail the diagnostic performance of cervical smears for upper tract and glandular lesions. METHODS: Pathology reports of cervical smears, hysterectomies, endometrial and cervical biopsies from 1995 to 2021 were retrieved. Diagnoses of cervical smears were matched to endometrial hyperplasias and carcinomas, or cervical carcinomas and reviewed. RESULTS: Totally 832 cervical smears (272 cervical carcinomas, 312 endometrial carcinomas, and 248 hyperplasias) were included. Considering all cytologic glandular diagnosis as positive, the detection rate of cervical adenocarcinoma‐in‐situ was the highest (64.3%), followed by cervical adenocarcinoma (63.8%), endometrial carcinoma (31.7%), and hyperplasia (with atypia–8.5%; without atypia–2.3%) (p < 0.001). Endometrial hyperplasia was most often diagnosed as atypical squamous cells of undetermined significance (ASCUS) (5.0%) or atypical glandular cells, not otherwise specified (3.6%) without indication of endometrial origin. For endometrial carcinomas, higher FIGO grading and endocervical involvement were associated with higher detection rates across all diagnostic categories (p = 0.002–0.028). High FIGO grade was associated with suspicious/favor neoplastic (C4) (31.1%vs10.3%, p < 0.001) and carcinoma (C5) (17.8% vs. 5.6%, p = 0.005) categories, but not for all glandular diagnoses combined (33.3% vs. 31.0%, p = 0.761). CONCLUSION: Detection rates for endometrial lesions are lower than cervical lesions but not insignificant. Endometrial hyperplasia should be recognized as a differential of human papilloma virus‐negative ASCUS and prompt consideration of investigation of the upper genital tract. John Wiley and Sons Inc. 2023-07-27 /pmc/articles/PMC10523982/ /pubmed/37501510 http://dx.doi.org/10.1002/cam4.6376 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | RESEARCH ARTICLES Ng, Joanna K. M. Cheung, Bryan H. C. Lee, Dennis H. Y. Li, Joshua J. X. Ip, Philip P. C. Lee, Jacqueline H. S. Yeung, Carol S. Y. Yu, Mei‐Yung Detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear |
title | Detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear |
title_full | Detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear |
title_fullStr | Detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear |
title_full_unstemmed | Detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear |
title_short | Detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear |
title_sort | detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear |
topic | RESEARCH ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523982/ https://www.ncbi.nlm.nih.gov/pubmed/37501510 http://dx.doi.org/10.1002/cam4.6376 |
work_keys_str_mv | AT ngjoannakm detectionratesandfactorsaffectingthereofinendometrialhyperplasiaendometrialcarcinomaandcervicalglandularlesionsoncervicalsmear AT cheungbryanhc detectionratesandfactorsaffectingthereofinendometrialhyperplasiaendometrialcarcinomaandcervicalglandularlesionsoncervicalsmear AT leedennishy detectionratesandfactorsaffectingthereofinendometrialhyperplasiaendometrialcarcinomaandcervicalglandularlesionsoncervicalsmear AT lijoshuajx detectionratesandfactorsaffectingthereofinendometrialhyperplasiaendometrialcarcinomaandcervicalglandularlesionsoncervicalsmear AT ipphilippc detectionratesandfactorsaffectingthereofinendometrialhyperplasiaendometrialcarcinomaandcervicalglandularlesionsoncervicalsmear AT leejacquelinehs detectionratesandfactorsaffectingthereofinendometrialhyperplasiaendometrialcarcinomaandcervicalglandularlesionsoncervicalsmear AT yeungcarolsy detectionratesandfactorsaffectingthereofinendometrialhyperplasiaendometrialcarcinomaandcervicalglandularlesionsoncervicalsmear AT yumeiyung detectionratesandfactorsaffectingthereofinendometrialhyperplasiaendometrialcarcinomaandcervicalglandularlesionsoncervicalsmear |